EMJ Rheumatology 9.1 2022

Welcome to our latest issue of EMJ Rheumatology, which includes a selection of original articles alongside a review the EULAR 2022 Congress with key highlights from the event. Featured articles include a review of metabolic syndrome and its outcomes in rheumatoid arthritis, and an article summarising the functions and regulations of Type I interferons in the pathogenesis of Sj√∂gren’s syndrome.